目的:探讨采用母亲体内IgG抗A(抗B)的效价积分对新生儿溶血病严重程度进行预判的价值。方法:检测27例新生儿溶血病患儿的红细胞计数、血红蛋白、红细胞比容和其母亲的IgG抗A(抗B)效价、效价积分,对其进行趋势线计算和相关性分析。结果:母亲的IgG抗A(抗B)效价积分和效价上升时,患儿的红细胞计数、血红蛋白含量、红细胞比容都下降;而在母亲抗体效价相同的情况下,效价积分越高,患儿的红细胞计数、血红蛋白含量、红细胞比容越低。相关性分析显示,在对新生儿溶血病患儿的贫血程度的预判中,效价积分与患儿血红蛋白含量间的相关系数为-0.966,其母亲的IgG抗A(抗B)效价积分与患儿贫血程度间的相关性比抗体效价更密切。结论:孕妇IgG抗A(抗B)的效价积分在预判患儿贫血的严重程度中具有一定临床价值。
Objective: To study the correlation of IgG anti-A/B titer score and the severity of hemolytic disease of newborn. Methods: The red blood cell count, hemoglobin and hematocrit value of 27 newborn with hemolytic disease and the IgG anti-A/B titer and titer score of their mother were measured and their correlations were analyzed. Results: With the increase in IgG anti-A/B titer and titer score of mother, the red blood cell count, hemoglobin and hematocrit values of newborn with hemolytic disease decreased. At the same IgG anti-A/B titer, the higher the titer score, the lower the red blood count, hemoglobin and hematocrit value were. Conclusions: According to the correlation analysis, the titer score is more closely related to the severity of hemolytic disease of newborn. For hemoglobin, the correlation coefficient was -0.966. The IgG anti-A/B titer score was of more clinical significance in predicting the severity of hemolytic disease in newborn.
[1] John DR, Martha RC, Christopher DH, et al. Technical Manual[M]. 16th edition.Hardcove,2008, Chapter 22:625.
[2] Harvey G. Klein, David J. Anstee. Mollison's Blood Transfusion in Clinical Medicine[M]. 9th edition. Wiley-Blackwell,2014, Chapter 12:531.
[3] Roback JD, Grossman BJ, Harris T, et al.Technical manual[M].16th edition.American Association of Blood Banks,2014:909-911.
[4] John DR, Martha RC, Christopher DH, et al. Technical Manual[M]. 16th edition.Hardcove,2008, 3-8:911-913.
[5] 刘达庄. 免疫血液学[M]. 上海科学技术出版社,2002:128-137.
[6] John DR, Martha RC, Christopher DH, et al. Technical Manual[M]. 16th edition.Hardcove,2008, Chapter 15:444.